John C. Martin
2007 - Gilead Sciences
In 2007, John C. Martin earned a total compensation of $10.8M as Chairman and Chief Executive Officer at Gilead Sciences, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,617,000 |
|---|---|
| Option Awards | $6,506,305 |
| Salary | $1,045,833 |
| Stock Awards | $1,628,601 |
| Other | $3,800 |
| Total | $10,801,539 |
Martin received $6.5M in option awards, accounting for 60% of the total pay in 2007.
Martin also received $1.6M in non-equity incentive plan, $1M in salary, $1.6M in stock awards and $3.8K in other compensation.
Rankings
In 2007, John C. Martin's compensation ranked 255th out of 8,700 executives tracked by ExecPay. In other words, Martin earned more than 97.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 255 out of 8,700 | 97th |
Division Manufacturing | 71 out of 3,314 | 98th |
Major group Chemicals And Allied Products | 15 out of 746 | 98th |
Industry group Drugs | 10 out of 546 | 98th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 118 | 99th |
Source: SEC filing on March 12, 2009.
Martin's colleagues
We found five more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2007.
2007
John Milligan
Gilead Sciences
Chief Operating Officer
2007
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2007
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2007
Gregg Alton
Gilead Sciences
General Counsel
2007
Caroline Dorsa
Gilead Sciences